Plain-English translation of NCT06055621 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a medication called for people with acute myeloid leukemia (a serious blood cancer) whose disease did not improve after trying a standard two-drug combination. The study wants to see if the medication works better as a single treatment for patients who cannot tolerate or are not eligible for traditional chemotherapy.
Many people with acute myeloid leukemia cannot benefit from standard chemotherapy, and when the usual drug combination fails, there are limited options. This trial is exploring whether this medication might offer a new hope for patients whose cancer has become resistant to earlier treatments.
You likely qualify if…
You likely don't qualify if…
You would receive the medication for up to 3 months. Your doctors will check how your cancer is responding by doing blood tests and a bone marrow test at the end of each treatment cycle. After the treatment phase ends, you'll be followed for an additional 6 months to monitor your health and how you're doing.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
France